15-78618839-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000743.5(CHRNA3):c.159A>G(p.Val53Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 1,613,816 control chromosomes in the GnomAD database, including 117,850 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 10647 hom., cov: 33)
Exomes 𝑓: 0.38 ( 107203 hom. )
Consequence
CHRNA3
NM_000743.5 synonymous
NM_000743.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.197
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 15-78618839-T-C is Benign according to our data. Variant chr15-78618839-T-C is described in ClinVar as [Benign]. Clinvar id is 1209688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.197 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA3 | NM_000743.5 | c.159A>G | p.Val53Val | synonymous_variant | Exon 2 of 6 | ENST00000326828.6 | NP_000734.2 | |
CHRNA3 | NM_001166694.2 | c.159A>G | p.Val53Val | synonymous_variant | Exon 2 of 6 | NP_001160166.1 | ||
CHRNA3 | XM_006720382.4 | c.-43A>G | 5_prime_UTR_variant | Exon 2 of 6 | XP_006720445.1 | |||
CHRNA3 | NR_046313.2 | n.361A>G | non_coding_transcript_exon_variant | Exon 2 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.371 AC: 56346AN: 152044Hom.: 10641 Cov.: 33
GnomAD3 genomes
AF:
AC:
56346
AN:
152044
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.353 AC: 88657AN: 251302Hom.: 16512 AF XY: 0.357 AC XY: 48490AN XY: 135852
GnomAD3 exomes
AF:
AC:
88657
AN:
251302
Hom.:
AF XY:
AC XY:
48490
AN XY:
135852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.380 AC: 555700AN: 1461654Hom.: 107203 Cov.: 51 AF XY: 0.378 AC XY: 274522AN XY: 727122
GnomAD4 exome
AF:
AC:
555700
AN:
1461654
Hom.:
Cov.:
51
AF XY:
AC XY:
274522
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.371 AC: 56389AN: 152162Hom.: 10647 Cov.: 33 AF XY: 0.367 AC XY: 27285AN XY: 74390
GnomAD4 genome
AF:
AC:
56389
AN:
152162
Hom.:
Cov.:
33
AF XY:
AC XY:
27285
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
909
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Urinary bladder, atony of Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at